|
Report Date : |
29.03.2014 |
IDENTIFICATION DETAILS
|
Name : |
MACROMED SARL |
|
|
|
|
Registered Office : |
Hassouneh Building, Midhar Pacha Street, Al Zareef Area, P
O Box111299, Beirut 11072080 |
|
|
|
|
Country : |
Lebanon |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
16.01.2003 |
|
|
|
|
Com. Reg. No.: |
1000858, Beirut |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
importer and distributor of medical products,
drugs and medicines. |
|
|
|
|
No. of Employees |
66 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – december 01, 2013
|
Country Name |
Previous Rating (30.09.2013) |
Current Rating (01.12.2013) |
|
Lebanon |
B2 |
b2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Lebanon ECONOMIC OVERVIEW
Lebanon has a free-market economy and a strong laissez-faire commercial
tradition. The government does not restrict foreign investment; however, the
investment climate suffers from red tape, corruption, arbitrary licensing
decisions, complex customs procedures, high taxes, tariffs, and fees, archaic
legislation, and weak intellectual property rights. The Lebanese economy is
service-oriented; main growth sectors include banking and tourism. The 1975-90
civil war seriously damaged Lebanon's economic infrastructure, cut national
output by half, and derailed Lebanon's position as a Middle Eastern entrepot
and banking hub. Following the civil war, Lebanon rebuilt much of its war-torn
physical and financial infrastructure by borrowing heavily - mostly from
domestic banks - saddling the government with a huge debt burden. Pledges of economic
and financial reforms made at separate international donor conferences during
the 2000s have mostly gone unfulfilled, including those made during the Paris
III Donor Conference in 2007 following the July 2006 war. The collapse of the
government in early 2011 over its backing of the Special Tribunal for Lebanon
and unrest in neighboring Syria slowed economic growth to the 1-2% range in
2011-12, after four years of 8% average growth. In September 2011 the Cabinet
endorsed a bill that would provide $1.2 billion in funding to improve
Lebanon''s downtrodden electricity sector, but fiscal limitations will test the
government''s ability to invest in other areas, such as water.
|
Source : CIA |
Company Name : MACROMED SARL
Country of Origin : Lebanon
Legal Form : Limited Liability Company
Registration Date : 16th January 2003
Commercial Registration Number : 1000858, Beirut
Issued Capital : LP 5,000,000
Paid up Capital : LP 5,000,000
Total Workforce : 66
Activities : Distributors of medical products, drugs and medicines.
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
MACROMED SARL
Registered &
Physical Address
Building : Hassouneh Building
Street : Midhar Pacha Street
Area : Al Zareef Area
PO Box : 111299
Town : Beirut 11072080
Country : Lebanon
Telephone : (961-1) 735463 / 735197
Facsimile : (961-1) 735198 / 735201
Email : macromed@cyberia.net.lb
Premises
Subject operates
from a medium sized suite of offices and a warehouse that are owned and located
in the Central Business Area of Beirut.
Name Position
·
Dr
Rabih Mohamed Hassouneh Managing
Director
·
Hilal
Mohamed Hassouneh Director
·
Abdullah
Mohamed Hassouneh Director
·
Zuha
Chaaban Sales
Manager
·
Suha
Kabbany Finance
Manager
·
Sally
Yaman Administration
Manager
·
Rola
Ghali Human
Resources Manager
·
Layal
Khalil Supervisor
Date of Establishment : 16th
January 2003
Legal Form :
Limited Liability Company
Commercial Reg. No. : 1000858,
Beirut
Issued Capital : LP 5,000,000
Paid up Capital : LP 5,000,000
Name of Shareholder
(s)
·
Dr Rabih
Mohamed Hassouneh
·
Hilal
Mohamed Hassouneh
·
Abdullah
Mohamed Hassouneh
Activities: Engaged in the import and distribution of
medical products, drugs and medicines.
Import
Countries: Europe and the
Far East
International
Suppliers:
·
Egyptian
International Pharmaceutical Industries Co Egypt
Agencies Held:
·
Ursapharm
Arznneimittel GmbH
·
Eusan
·
Claris
·
Midpharma
·
Hayat
·
Floxia
·
Ganassini
·
Moltenifarma
·
Kedrion
·
Alet
·
ABC
·
Biomet
·
Lupin
Brand Names: PINTAL, ABROLEN, INTERNATIONAL FLUTTER
VRP1, CIPROX, PROVIVE, HESTAR, LEVOXIN, METRIS, BUPICAN, BUPICAN HEAVY,
EMISTOP, ZINCOFLU, DROF SHAMPOO, CYTAROSE SOLUTION, HAPPY DEEF, HAPPY
DEEF WITH IRON and OCEAN SPRAY
Operating Trend: Steady
Subject has a
workforce of 66 employees.
Financial
highlights provided by local sources are given below:
Currency: Lebanese
Pounds (LP)
Year
Ending 31/12/12: Year Ending
31/12/13:
Total Revenue LP 5,875,000,000 LP 6,000,000,000
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
·
Banque
de la Mediterranee SAL
Al Nahar Building
Banque du Liban Street
Hamra
Beirut
Tel: (961-1) 353146
·
Arab
Bank Plc
PO Box: 111015
Beirut
Tel: (961-1) 370122 / 370155 / 862860
Fax: (961-1) 868130 / 602408
No complaints
regarding subject’s payments have been reported.
Local sources
report that the subject’s operating history is clear with payment obligations
met in a generally timely manner. The financial position is satisfactory and
the company is deemed a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.09 |
|
UK Pound |
1 |
Rs.99.85 |
|
Euro |
1 |
Rs.82.58 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major sections
of this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.